Santa Barbara Asset Management’s Pfizer PFE Stock Holding History

Santa Barbara Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$364K	Sell	9,040 -4,594,170	-100%	-$184M	0.01%	52
2018 Q4	$191M	Buy	4,603,210 +8,702	+0.2%	+$361K	3.07%	8
2018 Q3	$192M	Sell	4,594,508 -44,984	-1%	-$1.73M	2.78%	10
2018 Q2	$160M	Sell	4,639,492 -109,399	-2%	-$3.74M	2.43%	16
2018 Q1	$160M	Buy	4,748,891 +27,785	+0.6%	+$955K	2.46%	19
2017 Q4	$162M	Sell	4,721,106 -31,452	-0.7%	-$1.07M	2.45%	20
2017 Q3	$161M	Buy	4,752,558 +14,101	+0.3%	+$453K	2.57%	11
2017 Q2	$151M	Sell	4,738,457 -52,735	-1%	-$1.66M	2.54%	14
2017 Q1	$156M	Buy	4,791,192 +229,302	+5%	+$7.23M	2.68%	11
2016 Q4	$141M	Buy	4,561,890 +326,617	+8%	+$9.97M	2.55%	16
2016 Q3	$136M	Sell	4,235,273 -1,226,281	-22%	-$41M	2.5%	19
2016 Q2	$182M	Buy	5,461,554 +37,746	+0.7%	+$1.2M	3.43%	3
2016 Q1	$153M	Buy	5,423,808 +551,487	+11%	+$15.8M	3.01%	5
2015 Q4	$149M	Buy	4,872,321 +105,115	+2%	+$3.31M	2.99%	8
2015 Q3	$142M	Sell	4,767,206 -52,391	-1%	-$1.68M	2.97%	8
2015 Q2	$153M	Buy	4,819,597 +68,651	+1%	+$2.24M	3.09%	7
2015 Q1	$157M	Buy	4,750,946 +104,519	+2%	+$3.32M	3.04%	5
2014 Q4	$137M	Sell	4,646,427 -183,494	-4%	-$5.26M	2.77%	10
2014 Q3	$136M	Sell	4,829,921 -15,320	-0.3%	-$430K	2.8%	10
2014 Q2	$136M	Sell	4,845,241 -95,192	-2%	-$2.71M	2.8%	6
2014 Q1	$151M	Sell	4,940,433 -64,618	-1%	-$1.93M	3.22%	2
2013 Q4	$145M	Sell	5,005,051 -57,900	-1%	-$1.69M	3.26%	2
2013 Q3	$138M	Buy	5,062,951 +326,913	+7%	+$8.89M	3.27%	1
2013 Q2	$126M	Buy	+4,736,038	New	+$131M	3.28%	2

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Santa Barbara Asset Management's PFE Position: Q1 2019 in Review

Santa Barbara Asset Management reduced its Pfizer (PFE) stake by 100% in Q1 2019, selling an estimated $184M and leaving 9,040 shares worth $364K. The position accounts for 0.01% of the portfolio, ranked #52.

Santa Barbara Asset Management first reported a position in PFE in Q2 2013 and has held it in 24 quarters since. The position peaked at $192M in Q3 2018. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

Santa Barbara Asset Management held 9,040 shares of Pfizer worth $364K as of Q1 2019.
Santa Barbara Asset Management sold 4,594,170 Pfizer shares in Q1 2019, an estimated $184M.
Pfizer made up 0.01% of Santa Barbara Asset Management's portfolio in Q1 2019, its #52 holding.
Santa Barbara Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 24 quarters since.
Santa Barbara Asset Management's Pfizer position peaked at $192M in Q3 2018.
2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Santa Barbara Asset Management's 13F filing for Q1 2019, filed 14 May 2019.